These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11027867)

  • 1. Synthesis of 2,3- and 3,4-methylenedioxyphenylalkylamines and their regioisomeric differentiation by mass spectral analysis using GC-MS-MS.
    Borth S; Hänsel W; Rösner P; Junge T
    Forensic Sci Int; 2000 Dec; 114(3):139-53. PubMed ID: 11027867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GC-MS studies on side chain regioisomers related to substituted methylenedioxyphenethylamines: MDEA, MDMMA, and MBDB.
    Awad T; Belal T; Maher HM; DeRuiter J; Clark CR
    J Chromatogr Sci; 2010 Oct; 48(9):726-32. PubMed ID: 20875234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GC-MS studies on the regioisomeric 2,3- and 3,4-methylenedioxyphenethylamines related to MDEA, MDMMA, and MBDB.
    Thigpen A; DeRuiter J; Clark CR
    J Chromatogr Sci; 2007; 45(5):229-35. PubMed ID: 17555628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of 3,4-methylenedioxyamphetamine analogs encountered in clandestine tablets.
    Furnari C; Ottaviano V; Rosati F; Tondi V
    Forensic Sci Int; 1998 Mar; 92(1):49-58. PubMed ID: 9627975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GC-MS studies on the regioisomeric methoxy-methyl-phenethylamines related to MDEA, MDMMA, and MBDB.
    Thigpen A; Awad T; Deruiter J; Clark CR
    J Chromatogr Sci; 2008; 46(10):900-6. PubMed ID: 19007498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid chromatographic and mass spectral analysis of 1-(3,4-methylenedioxyphenyl)-1-propanamines: regioisomers of the 3,4-methylenedioxyamphetamines.
    DeRuiter J; Clark CR; Noggle FT
    J Chromatogr Sci; 1990 Mar; 28(3):129-32. PubMed ID: 2273067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ion trap mass spectrometry for the characterization of N-methyl-1- (3,4-methylene-dioxyphenyl)-2-butanamine and N-ethyl-3,4- methylenedioxyamphetamine, two widely distributed street drugs.
    Garofano L; Santoro M; Patri P; Guidugli F; Bollani T; Favretto D; Traldi P
    Rapid Commun Mass Spectrom; 1998; 12(12):779-82. PubMed ID: 9650303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of N-methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine (MBDB) in urine from drug users.
    Kronstrand R
    J Anal Toxicol; 1996 Oct; 20(6):512-6. PubMed ID: 8889691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromatographic and spectroscopic methods of identification for the side-chain regioisomers of 3,4-methylenedioxyphenethylamines related to MDEA, MDMMA, and MBDB.
    Aalberg L; DeRuiter J; Noggle FT; Sippola E; Clark CR
    J Chromatogr Sci; 2003; 41(5):227-33. PubMed ID: 12841949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis markers in illegally manufactured 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine.
    Bohn M; Bohn G; Blaschke G
    Int J Legal Med; 1993; 106(1):19-23. PubMed ID: 8104465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid chromatographic and mass spectral analysis of 1-(3,4-methylenedioxyphenyl)-3-butanamines, homologues of 3,4-methylenedioxyamphetamines.
    Noggle FT; Clark CR; DeRuiter J
    J Chromatogr Sci; 1989 May; 27(5):240-3. PubMed ID: 2745665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excretion of MBDB and BDB in urine, saliva, and sweat following single oral administration.
    Kintz P
    J Anal Toxicol; 1997; 21(7):570-5. PubMed ID: 9399128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isomeric fluoro-methoxy-phenylalkylamines: a new series of controlled-substance analogues (designer drugs).
    Rösner P; Quednow B; Girreser U; Junge T
    Forensic Sci Int; 2005 Mar; 148(2-3):143-56. PubMed ID: 15639609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of six 'neuro-enhancing' phenidate analogs.
    Klare H; Neudörfl JM; Brandt SD; Mischler E; Meier-Giebing S; Deluweit K; Westphal F; Laussmann T
    Drug Test Anal; 2017 Mar; 9(3):423-435. PubMed ID: 28067464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiles of urine samples taken from Ecstasy users at Rave parties: analysis by immunoassays, HPLC, and GC-MS.
    Zhao H; Brenneisen R; Scholer A; McNally AJ; ElSohly MA; Murphy TP; Salamone SJ
    J Anal Toxicol; 2001; 25(4):258-69. PubMed ID: 11386639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qualitative analysis of seized synthetic cannabinoids and synthetic cathinones by gas chromatography triple quadrupole tandem mass spectrometry.
    Gwak S; Arroyo-Mora LE; Almirall JR
    Drug Test Anal; 2015 Feb; 7(2):121-30. PubMed ID: 24827678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods for the analysis of 1-(3,4-methylenedioxyphenyl)-2-butanamine and N-methyl-1-(3,4-methylenedioxyphenyl)-2-propanamine (MDMA).
    Noggle FT; Clark CR; Andurkar S; DeRuiter J
    J Chromatogr Sci; 1991 Mar; 29(3):103-6. PubMed ID: 1676403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positional isomer differentiation of synthetic cannabinoid JWH-081 by GC-MS/MS.
    Kusano M; Zaitsu K; Nakayama H; Nakajima J; Hisatsune K; Moriyasu T; Matsuta S; Katagi M; Tsuchihashi H; Ishii A
    J Mass Spectrom; 2015 Mar; 50(3):586-91. PubMed ID: 25800195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New psychoactive substances in substantive evidence in expert practice of the Department of Forensic Medicine, UJCM in the years 2010-2015.
    Maciów-Głąb M; Kula K; Kłys M; Rojek SD
    Arch Med Sadowej Kryminol; 2017; 67(3):178-200. PubMed ID: 29460609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and quantification of new designer drugs in human blood: Part 2 - Designer cathinones.
    Ammann D; McLaren JM; Gerostamoulos D; Beyer J
    J Anal Toxicol; 2012 Jul; 36(6):381-9. PubMed ID: 22593565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.